These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23946196)

  • 61. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
    Wanzeck K; Boyd KL; McCullers JA
    Am J Respir Crit Care Med; 2011 Mar; 183(6):767-73. PubMed ID: 20935106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
    Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
    Front Immunol; 2019; 10():1400. PubMed ID: 31312199
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.
    Fang Y; Banner D; Kelvin AA; Huang SS; Paige CJ; Corfe SA; Kane KP; Bleackley RC; Rowe T; Leon AJ; Kelvin DJ
    J Virol; 2012 Feb; 86(4):2229-38. PubMed ID: 22130540
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
    Ikonen N; Strengell M; Kinnunen L; Osterlund P; Pirhonen J; Broman M; Davidkin I; Ziegler T; Julkunen I
    Euro Surveill; 2010 Feb; 15(5):. PubMed ID: 20144443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.
    Krammer F; Pica N; Hai R; Tan GS; Palese P
    J Virol; 2012 Oct; 86(19):10302-7. PubMed ID: 22787225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.
    Guo CY; Tang YG; Qi ZL; Liu Y; Zhao XR; Huo XP; Li Y; Feng Q; Zhao PH; Wang X; Li Y; Wang HF; Hu J; Zhang XJ
    Immunobiology; 2015 Aug; 220(8):941-6. PubMed ID: 25708705
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A.
    Zhong Y; Cai J; Zhang C; Xing X; Qin E; He J; Mao P; Cheng J; Liu K; Xu D; Song H
    Virol J; 2011 Dec; 8():542. PubMed ID: 22171803
    [TBL] [Abstract][Full Text] [Related]  

  • 71. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination.
    Sangster MY; Baer J; Santiago FW; Fitzgerald T; Ilyushina NA; Sundararajan A; Henn AD; Krammer F; Yang H; Luke CJ; Zand MS; Wright PF; Treanor JJ; Topham DJ; Subbarao K
    Clin Vaccine Immunol; 2013 Jun; 20(6):867-76. PubMed ID: 23576673
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Life course exposures continually shape antibody profiles and risk of seroconversion to influenza.
    Yang B; Lessler J; Zhu H; Jiang CQ; Read JM; Hay JA; Kwok KO; Shen R; Guan Y; Riley S; Cummings DAT
    PLoS Pathog; 2020 Jul; 16(7):e1008635. PubMed ID: 32702069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
    PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serological responses following influenza A H1N1 2009 infection in adults.
    Tan S; Gordon DL; Honda-Okubo Y; Petrovsky N; Phillips P; Huddleston S; Sadlon TA
    J Infect; 2011 May; 62(5):388-93. PubMed ID: 21420426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
    Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
    J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.
    Lee AJ; Das SR; Wang W; Fitzgerald T; Pickett BE; Aevermann BD; Topham DJ; Falsey AR; Scheuermann RH
    J Virol; 2015 May; 89(10):5427-40. PubMed ID: 25741011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.